10x Genomics, Inc.
TXG · Nasdaq · SIC 3826: Laboratory Analytical Instruments · Market Cap: $2.8B · 1,178 employees
Business Summary
3 Item1A. Risk Factors 12 Item 1B. Unresolved Staff Comments 58 Item 1 C . Cybersecurity 58 Item 2. Properties 59 Item 3. Legal Proceedings 59 Item 4. Mine Safety Disclosures 59 PARTII Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 60 Item 6. [Reserved] 62 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 62 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 74 Item 8....
Latest Stock Quote
TXG 2026-05-26
$24.62
O:$24.02 H:$24.98 L:$23.03 Vol:2.0M VWAP:$24.5694
origin leaf: 8dec1269c039a372ac35b25697d11639d801ce0a08b5e420b96984a432c690ab
Next Earnings
Q2 FY2026 — expected 2026-08-08
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | TXG | discussed Artificial Intelligence | Q4 FY2025 |
| topic_mention | TXG | discussed Blockchain & Crypto | Q4 FY2025 |
| topic_mention | TXG | discussed Supply Chain | Q4 FY2025 |
| topic_mention | TXG | discussed Regulation | Q4 FY2025 |
| topic_mention | TXG | discussed Automotive | Q4 FY2025 |
| topic_mention | TXG | discussed Healthcare & Bio | Q4 FY2025 |
| topic_mention | TXG | discussed Platform & Ecosystem | Q4 FY2025 |
| metric | TXG gross margin | reported $68 percent | Q4 FY2025 |
| metric | TXG gross margin | reported $69 percent | Q4 FY2025 |
| guidance | TXG | guided Guidance 10x Genomics expects full year 2026 revenue to be in the range of $600 million | Q4 FY2025 |
| topic_mention | TXG | discussed Artificial Intelligence | Q4 FY2025 |
| topic_mention | TXG | discussed Semiconductor | Q4 FY2025 |
| topic_mention | TXG | discussed Capital Expenditure | Q4 FY2025 |
| topic_mention | TXG | discussed Supply Chain | Q4 FY2025 |
| topic_mention | TXG | discussed Sovereign & Government | Q4 FY2025 |
| topic_mention | TXG | discussed Automotive | Q4 FY2025 |
| topic_mention | TXG | discussed Healthcare & Bio | Q4 FY2025 |
| topic_mention | TXG | discussed Platform & Ecosystem | Q4 FY2025 |
| metric | TXG gross margin | reported $68 percent | Q4 FY2025 |
| guidance | TXG | guided guidance range, and closed the year with $599 million | Q4 FY2025 |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-02-13 | 2025-12-31 | 0001628280-26-007822 | EDGAR | 80K words |
| 2025-02-13 | 2024-12-31 | 0001770787-25-000013 | EDGAR | — |
| 2024-02-15 | 2023-12-31 | 0001770787-24-000017 | EDGAR | — |
| 2023-02-16 | 2022-12-31 | 0001770787-23-000012 | EDGAR | — |
| 2022-02-18 | 2021-12-31 | 0001770787-22-000015 | EDGAR | — |
| 2021-02-26 | 2020-12-31 | 0001770787-21-000009 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001193125-20-052640 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-07 | 2025-09-30 | 0001628280-25-050332 | EDGAR | 16K words |
| 2025-08-08 | 2025-06-30 | 0001770787-25-000051 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001770787-25-000032 | EDGAR | — |
| 2024-10-29 | 2024-09-30 | 0001770787-24-000073 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001770787-24-000060 | EDGAR | — |
| 2024-04-30 | 2024-03-31 | 0001770787-24-000036 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001770787-23-000053 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0001770787-23-000047 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001770787-23-000029 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001770787-22-000057 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001770787-22-000049 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0001770787-22-000029 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-02-12 | 0001628280-26-007673 | EDGAR | 3K words |
| 2026-01-12 | 0001628280-26-001808 | EDGAR | — |
| 2025-11-14 | 0001628280-25-052154 | EDGAR | — |
| 2025-11-06 | 0001770787-25-000058 | EDGAR | — |
| 2025-08-07 | 0001770787-25-000048 | EDGAR | — |
| 2025-06-05 | 0001770787-25-000040 | EDGAR | — |
| 2025-05-14 | 0001770787-25-000035 | EDGAR | — |
| 2025-05-08 | 0001770787-25-000031 | EDGAR | — |
| 2025-02-12 | 0001770787-25-000011 | EDGAR | — |
| 2025-01-13 | 0001770787-25-000003 | EDGAR | — |
99 total filings indexed. 70 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Earnings Transcripts
| Call Date | Quarter | Title |
|---|
| — | Q4 FY2025 | TXG Q4 FY2025 Earnings Call Transcript |
| — | Q4 FY2025 | TXG Q4 FY2025 Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
Sector Peers
Company Identity
| CIK | 0001770787 |
| Ticker | TXG |
| Exchange | Nasdaq |
| SIC | 3826: Laboratory Analytical Instruments |
| Incorporated | DE |
| Website | https://www.10xgenomics.com |
| Listed | 2019-09-12 |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 28aa844cd58a508002480ad6459901325be388c42ed00057290c996e0b568e7d
parent: c526c7f17b520838de70508b15c3f882fbbb081fe007a5a1c7c3b824de5c4a92
content hash: 7c599c330c7d4d22f0626c1b160479edfb1250ea3f8c2ab2a9e152426c8fbc61
signed: 2026-06-02T19:02:55.905Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf